Purchase Order 75D30119P04644
- Not listed
- This is a $149,550 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Nanostring Technologies, Inc., a publicly traded manufacturer of genomic analysis platforms and life science tools. The contract is for the provision of Nanostring's nCounter Profiler system, which enables multiplexed digital detection and counting of nucleic acids, proteins, and cells. This award was not set aside for any specific business category. Nanostring Technologies has...
- This $95,320 firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Nanostring Technologies, Inc., a publicly traded provider of advanced genomic analysis platforms and life science tools. The contract is for the delivery of "GENE SETS", with an ultimate completion date of March 30, 2019. Nanostring is a manufacturer of goods and has provided a wide range of products and services to various federal agencies through past prime and...
- This is a firm-fixed price purchase order contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Nanostring Technologies, Inc., a publicly held manufacturer of life science tools for translational research and molecular diagnostics. The $121,000.00 contract is for a service agreement to provide the agency with Nanostring's nCounter and Digital Analyzer platforms, which enable multiplexed, digital detection and counting of nucleic acids,...
- This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services' Centers for Disease Control and Prevention to Nanostring Technologies, Inc., a publicly traded manufacturer of life science tools. The contract is for the delivery of Nanostring's nCounter MAX Analysis System, a proprietary platform for multiplexed, digital detection and counting of nucleic acids, proteins, and cells. The potential value of the contract is $236,000.00, with a completion...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price purchase order to Nanostring Technologies, Inc., a for-profit manufacturer, to provide a NCOUNTER SPRINT PROFILER. The $149,000.00 contract, which has no set-aside designation, was awarded on September 13, 2021 with a completion date of September 30, 2021. Nanostring Technologies, a publicly held provider of life science tools, has a history of delivering specialized laboratory...
- This $16,420 firm fixed-price purchase order was awarded by the National Institutes of Health (NIH) Clinical Center to Nanostring Technologies, Inc., a publicly traded provider of advanced genomic analysis platforms and life science tools for translational research and molecular diagnostics. The contract is not set aside for any specific business type. Under this award, Nanostring will deliver specialized laboratory equipment, reagents, assays, and testing services to support genomic, molecular,...
- This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Nanostring Technologies, Inc., a publicly held provider of life science tools for translational research and molecular diagnostics. The contract, valued at $17,832.50, is for the delivery of Nanostring's specialized laboratory equipment, reagents, assays, and testing services to support genomic, molecular, and cellular analysis for biomedical research and healthcare programs across...
- This is a $127,500 firm fixed-price Purchase Order contract awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Nanostring Technologies, Inc. for the NanoString nCounter Analysis System. The contract does not have a set-aside designation. Nanostring Technologies is a publicly traded provider of advanced genomic analysis platforms and life science tools. Through this contract, they are supplying specialized laboratory equipment, reagents, assays,...
- This $93,359 firm fixed-price purchase order was awarded to Nanostring Technologies, Inc., a publicly traded provider of advanced genomic analysis platforms and life science tools, by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services. The contract is for the delivery of Nanostring's proprietary nCounter and GeoMx analysis systems, reagents, and consumables to support genomic, molecular, and cellular...
- This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Nanostring Technologies, Inc., a publicly-held provider of life science tools for biomedical research and diagnostics. The $17,880 contract is for preventative maintenance on Nanostring's proprietary nCounter Sprint SP_2106P0366 analysis systems. Nanostring has an extensive history of providing specialized laboratory equipment, consumables, and testing services to support...
This is a $59,600 firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Nanostring Technologies, Inc. for laboratory maintenance services. The contract has an ultimate completion date of April 9, 2023 and does not use a set-aside designation. Nanostring Technologies is a publicly traded manufacturer of life science tools, including instruments, consumables, and services for genomic, molecular, and cellular analysis. The company has an extensive history of providing specialized laboratory equipment and testing services to support federal biomedical research and healthcare programs. This award is part of Nanostring's existing contract vehicles with various agencies, including a $597,000 IDIQ contract with the USDA Agricultural Research Service and a $2.8 million blanket purchase agreement with the Defense Health Agency to supply custom assays, panels, and reagents.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00005 | Other Administrative Action | $0 | 6/10/24 | |
| P00004 | Other Administrative Action | $0 | 6/6/22 | |
| P00003 | Exercise an Option | $14.9k | 4/7/22 | |
| P00002 | Exercise an Option | $14.9k | 4/15/21 | |
| P00001 | Exercise an Option | $14.9k | 3/7/20 |